AAO 2008 Annual Meeting Day Two

Return to AAO 2008 Annual Meeting Podcast Center

Return to Ophthalmology Times Podcast Center

Related Videos
Related Content

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

June 1st 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Coave Therapeutics announces positive data from Phase I/II clinical trial of CTx-PDE6b

May 31st 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

New FDA blood donor recommendations could ease restrictions on cornea donations from gay, bisexual men

May 31st 2023

Preservative-free latanoprost vs BAK-preserved latanoprost

May 31st 2023

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

June 1st 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Coave Therapeutics announces positive data from Phase I/II clinical trial of CTx-PDE6b

May 31st 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

New FDA blood donor recommendations could ease restrictions on cornea donations from gay, bisexual men

May 31st 2023

Preservative-free latanoprost vs BAK-preserved latanoprost

May 31st 2023

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

June 1st 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Coave Therapeutics announces positive data from Phase I/II clinical trial of CTx-PDE6b

May 31st 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

New FDA blood donor recommendations could ease restrictions on cornea donations from gay, bisexual men

May 31st 2023

Preservative-free latanoprost vs BAK-preserved latanoprost

May 31st 2023
© 2023 MJH Life Sciences

All rights reserved.